Ubiquitous Pharmacogenomics (U-PGx)
  • Home
  • U-PGx
    • U-PGx Consortium
    • Work Packages
    • Deliverables
    • U-PGx Publications
    • Ethics
    • Scientific Advisory Board
  • PREPARE
    • Study Overview
    • Results
    • Pharmacogenomics guidelines (DPWG)
    • FAQ
    • Downloads & Web Resources
    • LIM Survey
    • Data Collection
    • Ethics
  • Education
    • Education material
    • Events Calendar
    • Upcoming U-PGx Events
    • Past U-PGx Events
    • Links
    • Other PGx Organizations
      • PGRN
  • News
  • Login Members
  • Contact

Author: matthias_samwald

U-PGx proposal invited to PHC-24 stage 2

Posted on January 29, 2015March 31, 2016 by matthias_samwald

The U-PGx proposal was invited to stage 2 reviews by the European commission. Only 11 of the 59 proposals from the first stage of the review process were invited to stage 2.

Posted in News

Posts navigation

Newer posts →

Recent Posts

  • Matching medication to DNA leads to 30% fewer side effects
  • U-PGx Personalized Medicine Symposium
  • bio.logis receives the E-Health Award Hessen 2021
  • 7th U-PGx Personalized Medicine Day
  • Dr. Cristina Lucía Dávila Fajardo obtains PhD degree in pharmacogenetics
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 668353.